According to Bloomberg, in a research note that was distributed to investors on Tuesday, stock analysts at Barclays boosted their price objective for British American Tobacco (LON: BATS) from GBX 4,400 ($53.17) to GBX 4,500 ($54.37). At this moment, the brokerage firm considers the stock “overweight” in terms of its portfolio composition. The price objective stated by Barclays would increase the value of the shares by 29.12% from where they are presently trading if they were to achieve that aim. Other brokerage companies have also submitted their views on BATS. This input has been provided. In research released on Thursday, July 28, Royal Bank of Canada suggested a higher price target for British American Tobacco. The previous price aim was GBX 3,100 ($37.46), but the new price objective is GBX 3,500 ($42.29), an increase from the last price objective. The financial institution also assigned the company the rating of “sector performs” for its performance in its industry.
In a research note published on Thursday, July 21, Deutsche Bank Aktiengesellschaft reaffirmed its “buy” rating on shares of British American Tobacco and set a target price of GBX 4,000 ($48.33) for the company’s stock. In a research note published on Thursday, July 28, JPMorgan Chase & Co. reaffirmed an “overweight” rating on shares of British American Tobacco. The firm also established a target of GBX 4,500 ($54.37) for the company’s stock. The research note on British American Tobacco was published by Goldman Sachs Group on Friday, June 17, and indicated that the firm’s target price for the company was GBX 4,000 ($48.33). In a research note that was published on Wednesday, August 17, Jefferies Financial Group advised a price of GBX 4,500 ($54.37) for British American Tobacco. The final and most crucial recommendation was this one. Five equity research specialists have recommended buying the stock, and one of those experts has recommended that investors go on and purchase the shares.
The information provided by Bloomberg indicates that the company is currently classified as having a consensus recommendation of “Moderate Buy,” with a target price of GBX 4,031.11 ($48.71), with the average target price being $48.51. When trading started on Tuesday, one share of British American Tobacco was valued at the cost of GBX 3,485 ($42.11), equivalent to the dollar amount. There is a debt-to-equity ratio of 60.59, a quick ratio of 0.47, and a current ratio of 0.88. All of these ratios are current as of right now. The company has a price-to-earnings balance of 1,469.96, and its market capitalization is £78.53 billion. In the previous fifty-two weeks, the price of British American Tobacco has ranged from as low as GBX 2,507.50 ($30.30) to as high as GBX 3,645 ($44.04), with an average price of GBX 2,507.50 ($30.30) throughout that period.
The company’s moving average for the last 50 days is presently resting at GBP 3,421.29, and the moving average for the past 200 days is currently sitting at GBP 3,361.77. Consumers in a wide range of nations can purchase tobacco and other nicotine products from British American Tobacco plc, a publicly-traded company. In addition to combustible and traditional oral nicotine products such as snus and wet snuff, it also sells vapor, tobacco heating, and contemporary oral nicotine products. Examples of conventional oral nicotine products include moist snuff and snus. The company makes and sells several brands, such as Kent, Dunhill, Lucky Strike, Pall Mall, Rothmans, Camel, Newport, Natural American Spirit, Vapour, THP, and Modern Oral.
